Terms: = Leukemia AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1
534 results:
1. Allogeneic transplantation for adult T-cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy.
Itonaga H; Fukushima T; Kato K; Nakano N; Kato T; Tanaka T; Eto T; Mori Y; Kawakita T; Uchida N; Fujioka M; Nakamae H; Ogata M; Morishima S; Fukuda T; Kanda Y; Atsuta Y; Fuji S; Yoshimitsu M
Hematol Oncol; 2024 Nov; 42(6):e3315. PubMed ID: 39367543
[TBL] [Abstract] [Full Text] [Related]
2. Increasing prostate cancer radiosensitivity by miR-7-5p knockdown of anti-apoptotic genes.
Darvish L; Bahreyni-Toossi MT; Aghaee-Bakhtiari SH; Akbari-Naserkiadeh A; Vaziri-Nezamdoust F; Azimian H
Gene; 2025 Jan; 933():148951. PubMed ID: 39303820
[TBL] [Abstract] [Full Text] [Related]
3. Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study.
Al-Sawaf O; Robrecht S; Zhang C; Olivieri S; Chang YM; Fink AM; Tausch E; Schneider C; Ritgen M; Kreuzer KA; Sivchev L; Niemann CU; Schwarer A; Loscertales J; Weinkove R; Strumberg D; Kilfoyle A; Manzoor BS; Jawaid D; Emechebe N; Devine J; Boyer M; Runkel ED; Eichhorst B; Stilgenbauer S; Jiang Y; Hallek M; Fischer K
Blood; 2024 Oct; 144(18):1924-1935. PubMed ID: 39082668
[TBL] [Abstract] [Full Text] [Related]
4. Peripheral Blood and Bone Marrow Findings in Treatment-Naive Patients With Cytopenia(s)/Myeloid Neoplasms Harboring Both a Germline and a Somatic DDX41 Mutation.
Bruehl FK; Elbaz Younes I; Bosler DS; Kelemen K; Jiang L; Reichard KK
Appl Immunohistochem Mol Morphol; 2024 Sep; 32(8):371-381. PubMed ID: 39046192
[TBL] [Abstract] [Full Text] [Related]
5. Real-world effectiveness of first-line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy.
Acker F; Chromik J; Tiedjen E; Wolf S; Vischedyk JB; Makowka P; Enßle JC; Kouidri K; Sebastian M; Steffen B; Oellerich T; Serve H; Neubauer A; Schäfer JA; Bittenbring JT
Eur J Haematol; 2024 Nov; 113(5):623-630. PubMed ID: 39023132
[TBL] [Abstract] [Full Text] [Related]
6. S1P Signaling Genes as Prominent Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic Myeloid leukemia.
Morang S; Bisht M; Upadhyay V; Thapliyal S; Handu S
OMICS; 2024 Jul; 28(7):367-376. PubMed ID: 38986084
[TBL] [Abstract] [Full Text] [Related]
7. TCL1A-expressing B cells are critical for tertiary lymphoid structure formation and the prognosis of oral squamous cell carcinoma.
Xie W; Lu J; Chen Y; Wang X; Lu H; Li Q; Jin N; He J; Ou L; Ni J; Shen Y; Shao L
J Transl Med; 2024 May; 22(1):477. PubMed ID: 38764038
[TBL] [Abstract] [Full Text] [Related]
8. Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study.
Ravandi F; Subklewe M; Walter RB; Vachhani P; Ossenkoppele G; Buecklein V; Döhner H; Jongen-Lavrencic M; Baldus CD; Fransecky L; Pardee TS; Kantarjian H; Yen PK; Mukundan L; Panwar B; Yago MR; Agarwal S; Khaldoyanidi SK; Stein A
Leuk Lymphoma; 2024 Sep; 65(9):1281-1291. PubMed ID: 38712673
[TBL] [Abstract] [Full Text] [Related]
9. Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Ye Y; Labopin M; Gérard S; Yakoub-Agha I; Blau IW; Aljurf M; Forcade E; Gedde-Dahl T; Burns D; Vydra J; Halahleh K; Hamladji RM; Bazarbachi A; Nagler A; Brissot E; Li L; Luo Y; Zhao Y; Ciceri F; Huang H; Mohty M; Gorin NC
Am J Hematol; 2024 Jul; 99(7):1290-1299. PubMed ID: 38654658
[TBL] [Abstract] [Full Text] [Related]
10. Pro-Inflammatory Activation Suppresses TRAIL-induced Apoptosis of Acute Myeloid leukemia Cells.
Kobyakova MI; Senotov AS; Krasnov KS; Lomovskaya YV; Odinokova IV; Kolotova AA; Ermakov AM; Zvyagina AI; Fadeeva IS; Fetisova EI; Akatov VS; Fadeev RS
Biochemistry (Mosc); 2024 Mar; 89(3):431-440. PubMed ID: 38648763
[TBL] [Abstract] [Full Text] [Related]
11. Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity.
Locke FL; Siddiqi T; Jacobson CA; Ghobadi A; Ahmed S; Miklos DB; Perales MA; Munoz J; Fingrut WB; Pennisi M; Gauthier J; Shadman M; Gowda L; Mirza AS; Abid MB; Hong S; Majhail NS; Kharfan-Dabaja MA; Khurana A; Badar T; Lin Y; Bennani NN; Herr MM; Hu ZH; Wang HL; Baer A; Baro E; Miao H; Spooner C; Xu H; Pasquini MC
Blood; 2024 Jun; 143(26):2722-2734. PubMed ID: 38635762
[TBL] [Abstract] [Full Text] [Related]
12. White Blood Cell Count, Neutrophil-to-Lymphocyte Ratio, and Incident Cancer in the UK Biobank.
Song M; Graubard BI; Loftfield E; Rabkin CS; Engels EA
Cancer Epidemiol Biomarkers Prev; 2024 Jun; 33(6):821-829. PubMed ID: 38568024
[TBL] [Abstract] [Full Text] [Related]
13. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
[No Abstract] [Full Text] [Related]
14. A Study on Geographic Correlation between Indoor Radon Exposure and leukemia Incidence in Canada.
Chen J
Health Phys; 2024 May; 126(5):315-321. PubMed ID: 38526250
[TBL] [Abstract] [Full Text] [Related]
15. Childbirth rates in women with myeloproliferative neoplasms.
Landtblom AR; Andersson TM; Johansson ALV; Lundberg FE; Samuelsson J; Björkholm M; Hultcrantz M
Leukemia; 2024 May; 38(5):1081-1085. PubMed ID: 38461191
[TBL] [Abstract] [Full Text] [Related]
16. First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia.
Jo T; Ueda T; Akahoshi Y; Kondo T; Uchida N; Tanaka M; Nakamae H; Doki N; Ota S; Sawa M; Ohigashi H; Maruyama Y; Takayama N; Nishida T; Hiramoto N; Katayama Y; Kanda Y; Ichinohe T; Atsuta Y; Arai Y;
Br J Haematol; 2024 May; 204(5):1913-1919. PubMed ID: 38420726
[TBL] [Abstract] [Full Text] [Related]
17. [Immune Reconstitution after BTKi Treatment in Chronic Lymphocytic leukemia].
Wang YL; Tang PX; Chen KL; Guo GY; Long JL; Zou YQ; Liang HY; Xu ZS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):1-5. PubMed ID: 38387891
[TBL] [Abstract] [Full Text] [Related]
18. Chronic Lymphocytic leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.
Grants JM; May C; Bridgers J; Huang S; Gillis S; Meissner B; Boyle M; Ben-Neriah S; Hung S; Duns G; Hilton L; Gerrie AS; Marra M; Kridel R; Sabatini PJB; Steidl C; Scott DW; Karsan A
Clin Chem; 2024 Jan; 70(1):273-284. PubMed ID: 38175592
[TBL] [Abstract] [Full Text] [Related]
19. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
20. Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax.
Jain N; Croner LJ; Allan JN; Siddiqi T; Tedeschi A; Badoux XC; Eckert K; Cheung LWK; Mukherjee A; Dean JP; Szafer-Glusman E; Seymour JF
Clin Cancer Res; 2024 Feb; 30(3):498-505. PubMed ID: 37955424
[TBL] [Abstract] [Full Text] [Related]
[Next]